ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing sorted by
relevance

Admin13.08.2021

ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing

5206
Admin19.07.2021

(PDF) Mechanistic and Pharmacodynamic studies of ADCT-301

52010
Admin31.07.2021

(PDF) Pre-Clinical Activity of Adct-301, a Novel

7101
Admin31.08.2021

(PDF) ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer

7700
Admin03.08.2021

ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing

3301
Admin07.09.2021

ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing

6706
Admin14.09.2021

ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing

506
Admin26.08.2021

ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing

1700
Admin14.09.2021

ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing

7808
Admin04.08.2021

(PDF) ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer

52010
Admin27.07.2021

(PDF) Antistaphylococcal activity of DNA-interactive

48010
Admin13.07.2021

(PDF) Pre-clinical pharmacology and mechanism of action of

7204
Admin29.09.2021

Antibody Drug Conjugates Differentiate Uptake and DNA

80010
Admin01.10.2021

Paul PARREN | Executive Vice President and Head of R&D | Ph.D.

7506
Admin14.07.2021

Researchers Evaluate Pyrrolobenzodiazepine(PBD)-dimers

202
Admin26.09.2021

Exploration of Pyrrolobenzodiazepine (PBD)-Dimers

8103
Admin31.08.2021

Preclinical Evaluation of ADCs Delivering Highly Potent

2409
Admin29.07.2021

A) Schematic diagram of the PBD dimer SJG-136 forming an

3205
Admin24.09.2021

A, averaged mean graphs for the cytotoxicity of SG2285

8205
Admin04.10.2021

QbD in the Development of ADCs with PBD Dimer Warheads

8501
Admin11.09.2021

Peter Hofland, Author at ADC Review ADC Review

6505